While another class of drugs (SGLT2 inhibitors) currently has stronger kidney-specific evidence, GLP-1 drugs appear to provide additional kidney protection, especially in patients with diabetes and obesity.Which categories of Indian patients should actively discuss GLP-1 drugs with their cardiologist
No, berberine is not generally recommended for long-term use
Retatrutide is an investigational drug not approved for human use
The 12-week OMGLean program is an all-inclusive investment of about $3,000, covering physician supervision, testing, 90 days of medication, lipotropic injections, and coaching support, with no hidden fees
While we await the final regulatory milestones for Retatrutide UK , our team continues to provide high-standard oversight for currently licensed treatments
Eli Lilly, which had co-marketed Byetta with Amylin, soon started developing its own GLP-1 compounds (e.g